Weaver W D, Cobb L A, Dennis D, Ray R, Hallstrom A P, Copass M K
Ann Intern Med. 1985 Jan;102(1):53-5. doi: 10.7326/0003-4819-102-1-53.
The amplitude of ventricular fibrillation found initially in 394 patients was compared to clinical and logistical findings at the time of cardiac arrest. Peak-to-peak amplitude averaged 0.55 +/- 0.25 mV; a very low amplitude (0.2 mV or less) or "fine" fibrillation was present in 66 patients (17%). The amplitude was not found to be related to clinical histories, but depended on the length of the period from collapse until start of basic life support (p = 0.004) and the delay until assessment by paramedics (p = 0.001). Survival rates were strongly associated with amplitude: only 4 patients (6%) with fine ventricular fibrillation survived, compared to 117 or 328 patients (36%) in whom the initial amplitude was higher (p less than 0.001). Patient outcome related to amplitude even after adjusting for clinical history and logistical delays (p less than 0.005). We conclude that fine ventricular fibrillation is in part the result of delay in initiation of treatment, and that fibrillation amplitude is a powerful indicator of outcome after cardiac arrest.
对394例患者最初发现的心室颤动幅度与心脏骤停时的临床和后勤情况进行了比较。峰峰值幅度平均为0.55±0.25mV;66例患者(17%)存在极低幅度(0.2mV或更低)或“细”颤动。未发现幅度与临床病史相关,但取决于从晕倒至开始基本生命支持的时间长度(p = 0.004)以及至护理人员评估的延迟时间(p = 0.001)。生存率与幅度密切相关:仅有4例(6%)细心室颤动患者存活,相比之下,初始幅度较高的117例或328例患者中有36%存活(p<0.001)。即使在调整临床病史和后勤延迟因素后,患者预后仍与幅度相关(p<0.005)。我们得出结论,细心室颤动部分是治疗开始延迟的结果,并且颤动幅度是心脏骤停后预后的有力指标。